Which are the mechanisms regulating malignant B lymphocyte growth, fitness and resilience to cytotoxic agents?
Non-Hodgkin lymphomas (NHL) and multiple myeloma (MM) are B-cell derived tumours and represent the vast majority of hematologic cancers, in many instances still incurable. We aim at defining the determinants of intrinsic and extrinsic growth signals for NHL and MM cells. Our laboratory is particularly interested in identifying novel regulators of cellular fitness and stress resistance to be targeted in novel therapeutic approaches for NHL and MM.
- • MD, University of Padova, Italy (1995)
- Board in Medical Oncology, University of Padova, Italy (2000)
- Postdoc: Memorial Sloan-Kettering Cancer Center, New York, USA (1999-2003)
- Assistant Professor of Hematology, Dept. of Medicine, University of Padua (since 2008)
- Group leader: Hematological Malignancies, Lymphoma and Myeloma Pathobiology, Venetian Institute of Molecular Medicine, Padua, Italy (since 2013)
- 2004: Brian D. Novis Junior Award, International Myeloma Foundation (USA)
- 2006: “Guido Berlucchi” Award for young oncologists, Italy